Central administration of palmitoylethanolamide cuts down hyperalgesia in mice through inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol All a few scientific studies are in step with current literature on PEA’s sizeable therapeutic index, that makes it an interesting applicant for the main line therapy https://whatisproleviate32097.thelateblog.com/30036501/the-ultimate-guide-to-palmitoylethanolamide